Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice
- 27 March 2008
- journal article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 24 (5) , 1309-1316
Abstract
Objective: This prospective, observational, open study aimed to assess the efficacy and safety of hylan G-F 20 in a large cohort of patients with symptomatic hip osteoarthritis (OA), and identify predictors of clinical response.Research design and methods: Patients presenting with symptomatic hip OA received one 2 mL intra-articular (IA) injection of hylan G-F 20 under ultrasound guidance. Patients were followed-up every 3 months for a total of 12 months and were offered an optional, additional injection at each follow-up visit if symptomatically justified. At each visit, pain scores (100 mm visual analogue scale [VAS]), Lequesne index scores, NSAID intake, and physician and patient global assessments scores were recorded. Adverse events (AEs) were recorded throughout the study.Main outcome measures; results: 250 patients completed the 12 month follow-up and received a total of 734 injections. Statistically significant reductions in VAS pain scores, Lequesne index scores and NSAID usage were repor...Keywords
This publication has 32 references indexed in Scilit:
- EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2005
- A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical resultsOsteoarthritis and Cartilage, 2002
- A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritisArthritis Research & Therapy, 2002
- Evidence-based management of osteoarthritis: practical issues relating to the dataBest Practice & Research Clinical Rheumatology, 2001
- EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Annals of the Rheumatic Diseases, 2000
- Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 updateArthritis & Rheumatism, 2000
- Viscosupplementation with Hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic kneeClinical Therapeutics, 1998
- The role of viscosupplementation with hylan G-F 20 (Synvisc®) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs aloneOsteoarthritis and Cartilage, 1995
- Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organizationArthritis & Rheumatism, 1995
- Idiopathic Symptomatic Osteoarthritis of the Hip and Knee: A Population-Based Incidence StudyMayo Clinic Proceedings, 1990